Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal ART regimen for them. Stream this podcast to listen as Dima Dandachi, MD, MPH, FIDSA, FACP, and Chloe Orkin, MBChB, FRCP, MD, discuss key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and quality of life associated with switching a suppressive ART regimen.
Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal antiretroviral therapy (ART) regimen for them. Stream this Medical Minute to learn more about key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and quality of life associated with switching a suppressive ART regimen. Topics covered include:
Presenters:
Dima Dandachi, MD, MPH, FIDSA, FACP
Associate Professor of Medicine
Division of Infectious Diseases
University of Missouri
Medical Director
HIV Treatment and Prevention Program, MUHC
Medical Director
Boone County Public Health and Human Services
Columbia, Missouri
Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom
Link to full program and accompanying slides:
https://bit.ly/3KPN0xb
Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.